Brind.

IgAN is developing a targeted-release budesonide therapy, with an NDA submission targeted for the end of 2026.

1 report, 1 independent Updated Jul 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Japan Mylan

Keep exploring

The entities involved

Japan
- Japan is deepening economic cooperation with Sri Lanka through knowledge exchange, guided by Japanese principles.Mon 11:09
- Sri Lanka joined the Sterling Assets Agreement and participated in the San Francisco Conference.Mon 11:09
Mylan
former pharmaceutical company
- Mylan and Zymeworks are involved in a deal aimed at bolstering Zymeworks’ commercial portfolio, related to COPD therapy.Mon 11:01
- Zymeworks is leveraging Irish tax attributes as part of its deal with Mylan.Mon 11:01

Coverage

Newest first; wire copies grouped

Jul 5yahoo.com